No Detail Found!

Investigating Hesperidin as a potential neuroprotective agent for Autism-induced Rats Models

Author(s)
Pirya Nangdev Departments of Anatomy, Bilawal Medical College Liaquat University of Medical and Health Sciences (LUMHS), Jamshoro, Pakistan
Rabia Bughio Departments of Anatomy, LUMHS, Lahore, Pakistan
Amber Ghani Departments of Anatomy, Mekran Medical College Turbat, Balochistan, Pakistan
Khalida Parveen Departments of Anatomy, LUMHS, Lahore, Pakistan
Monika Wadhwa Departments of Anatomy, Population Welfare Department, Govt. of Sindh, Pakistan
Hafiz Muhammad Haseeb Khaliq Department of Pathology, Forman Christian College, Lahore, Pakistan
Abstract
Objective: To explore the neuroprotective potential of hesperidin in rats that have been exposed to propionic acid-induced autism and correlation assessment analysis with serum BDNF levels, a biomarker for neuroprotection. Methodology: The study included 25 healthy male 7 weeks-old Sprague-Dawley rats and five groups were designed. Group I included physiological rats (n=5) that were not induced, while the other groups (n=20) received intraperitoneal injections of propionic acid (250 mg/kg/day) for 5 days. Group II was exclusively made up of rats that had been induced with PPA. Groups III, IV, and V involved the rats that were given different dosages of hesperidin (100 mg/kg, 200 mg/kg, and 400 mg/kg, respectively) mixed into their diet for a 24-day period. Hesperidin effects were assessed by measuring BDNF levels via ELISA kits. One-way ANOVA (post hoc Tukeys test) were used in statistical analysis. Results: Significant recovery of serum BDNF levels was seen in the Hesperidin treated groups (III, IV and V) relative to the PPA-induced group (II). Hesperidin therapy greatly reduced autism-like problems. The measured BDNF levels (ng/ml) were as Group I (15.2±0.5), II (6.8±0.4), III (10.3±0.5), IV (13.0±0.6) and V (14.7±0.5). Significant differences between the groups were found using a one-way ANOVA (p<0.001). BDNF levels in Groups III, IV, and V were considerably greater than those in Group II (PPA-induced), according to the post-hoc Tukeys test (p<0.05). Conclusion: Increased BNDF levels in a mouse model of PPA-induced autism supported the neuroprotective effects of hesperidin.
Publication Details
Page(s) 665-668
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 49, Issue: 3, Year: 2024

Request the full text from PASTIC

Keywords
Neurodegeneration, BDNF, autism, Autism-induced Models, pro-pionic acid, hesperidin.
References
Al-Dewik N,Al-Jurf R,Styles M,Tahtamouni S,Alsharshani D,Alsharshani M .2020 .Overview and introduction to autism spectrum disorder (ASD). Autism Res Treatment, 24 : 3-42.
Meeking MM,MacFabe DF,Mepham JR,Foley KA,Tichenoff LJ,Boon FH .2020 .Propionic acid induced behavioural effects of relevance to autism spectrum disorder evaluated in the hole board test with rats. Behav Brain Res, 97 : 109794.
Scoditti E. .2020 .Neuroinflammation and neurodegeneration: The promising protective role of the citrus flavanone hesperetin. Nutrients, 12 : 2336.
Li X,Huang W,Tan R,Xu C,Chen X,Li S .2023 .The benefits of hesperidin in central nervous system disorders, based on the neuroprotective effect. Biomed Pharmacotherapy, 159 : 114222.
Yurtal Z,Altuğ EM,Unsaldı E,Secıntı Eİ,Kucukgul A .2020 .Investigation of neuroprotective and therapeutic effects of hesperidin in experimental spinal cord injury. Neurosci Letters, 715 : 134631.
Cappoli N,Tabolacci E,Aceto P,Russo D. .2020 .The emerging role of the BDNF-TrkB signaling pathway in the modulation of pain perception. J Neurosci Res, 98 : 1436-1449.
Abdelli LS,Samsam A,Naser SA .2019 .Propionic acid induces gliosis and neuro-inflammation through modulation of PTEN/AKT pathway in autism spectrum disorder. Scientific Rep, 9 : 8824.
Ibrahim AM,Chauhan L,Bhardwaj A,Sharma A,Fayaz F,Kumar B .2022 .Brain-derived neurotropic factor in neurodegenerative disorders. Front Neurosci, 10 : 1143-7.
Liu X,Lin J,Zhang H,Khan NU,Zhang J,Tang X .2022 .Oxidative stress in autism spectrum disorder-current progress of mechanisms and biomarkers. Front Psychiatry, 13 : 813304-7.
Antunes MS,Cattelan Souza L,Ladd FVL,Ladd AABL,Moreira AL,Bortolotto VC .2020 .Hesperidin ameliorates anxiety-depressive-like behavior in 6-OHDA model of Parkinson's disease by regulating striatal cytokine and neurotrophic factors levels and dopaminergic innervation loss in the striatum of mice. Behav Brain Res, 57 : 3027-41.
Amini F,Amini-Khoei H,Haratizadeh S,Setayesh M,Basiri M,Raeiszadeh M .2023 .Hydroalcoholic extract of Passiflora incarnata improves the autistic-like behavior and neuronal damage in a valproic acid-induced rat model of autism. Molecular Neurobiol, 60 : 315-24.
Abdollahi H,Edalatmanesh MA,Hosseini E,Foroozanfar M. .2021 .The effects of hesperidin on BDNF/TrkB signaling pathway and oxidative stress parameters in the cerebral cortex of the utero-placental insufficiency fetal rat model. Brain Res Bull, 174 : 73-81.
Alhusaini A,Hasan IH,Alrumayyan B,Alesikri M,Alanazi K,Almasoud R .2020 .Neuroprotective efficacy of nano‐CoQ against propionic acid toxicity in rats: Role of BDNF and CREB protein expressions. J Biochem Molecular Toxicol, 34 : 22449-53.
Saad AK,Akour A,Mahboob A,AbuRuz S A .2022 .Role of brain modulators in neurodevelopment: focus on autism spectrum disorder and associated comorbidities. J Pediatr Neurol, 15 : 612-23.
Alsubaiei SRM,Alfawaz HA,Bhat RS,El-Ansary A .2023 .Nutritional intervention as a complementary neuroprotective approach against propionic acid-induced neurotoxicity and associated biochemical autistic features in rat pups. Nutrients, 15 : 738-42.
Barbosa AG,Pratesi R,Paz GSC,Dos Santos MAAL,Uenishi RH,Nakano EY .2020 .Assessment of BDNF serum levels as a diagnostic marker in children with autism spectrum disorder. Scientific Rep, 10 : 17348.
Cichon N,Saluk-Bijak J,Gorniak L,Przyslo L,Bijak M .2020 .Flavonoids as a natural enhancer of neuroplasticity-An overview of the mechanism of neurorestorative action. Nutrients, 12 : 1035-9.
Guazelli CF,Fattori V,Ferraz CR,Borghi SM,Casagrande R,Baracat MM .2021 .Antioxidant and antiinflammatory effects of hesperidin methyl chalcone in experimental ulcerative colitis. Chemico-Biol Interactions, 333 : 109315.
Sharma P,Kumari S,Sharma J,Purohit R,Singh D. .2021 .Hesperidin interacts with CREB-BDNF signaling pathway to suppress pentylenetetrazole-induced convulsions in zebrafish. Front Pharmacol, 11 : 607797.
Hajialyani M,Hosein Farzaei M,Echeverría J,Nabavi SM,Uriarte E,Sobarzo-Sánchez E .2019 .Hesperidin as a neuroprotective agent: a review of animal and clinical evidence. Molecules, 24 : 648-52.
Joshi S,Dhingra AK,Chopra B,Guarve K,Bhateja D .2022 .Therapeutic potential and clinical evidence of hesperidin as neuroprotective agent. Central Nervous Sys Agents Medicinal Chem, 22 : 5-14.
Li X,Huang W,Tan R,Xu C,Chen X,Li S .2023 .The benefits of hesperidin in central nervous system disorders, based on the neuroprotective effect. Biomed Pharmacotherapy, 159 : 114222.
0

Citations

0

Downloads

64

Views